	销售和管理费用		日
Akebia Therapeutics	USD 23.53M	3.19M	2025-12
Alaunos Therapeutics	USD 447K	138K	2026-03
ALKERMES	USD 196.64M	67.96M	2026-06
Avita Medical	AUD 19.03M	1.95M	2025-12
Dianthus Therapeutics	USD 12.47M	5.89M	2026-03
Eurofins Scientific SE	EUR 0	0	2023-06
Ionis Pharmaceuticals	USD 130.07M	20.92M	2026-06
IQVIA Holdings	USD 574M	72M	2026-06
Malin Corporation	EUR 1.1M	400K	2024-12
Moderna	USD 216M	43M	2026-06
Organon & Co	USD 424M	9M	2026-03
Ovoca Bio	EUR 617K	15K	2025-12
Revvity	USD 278.58M	24.69M	2026-06
Tectonic Therapeutic	USD 6.43M	2.99M	2026-03
Viatris	USD 928.8M	101.9M	2026-03
Xeris Pharmaceuticals	USD 53.14M	10.51M	2026-03